News Detail
Mumbai, 11 Jan 2025: With revision in extension of the deadline for implementing the revised Schedule M until December 31, 2025, the Indian Drug Manufacturers’ Association (IDMA) has announced plans to intensify its capacity-building initiatives to help pharmaceutical micro......
View Details
Source : Pharmabiz
Deadline
revised Schedule M
Indian Drug Manufacturers’ Association
IDMA
MSMEs
Union ministry of health
Central License Approving Authority
CDSCO
AIPAC
GMP
PQS
PQR
Gujarat FDCA
Related News
- FDA Revokes Use of 'FD&C Red No.3' in Foods and Drugs (16-01-2025)
- Dabur sues Patanjali over toothpaste trade dress (16-01-2025)
- Wrappers of drug brands found from Paonta printing press premises (16-01-2025)
- PCI revises list of pharmacists blocked on DIGI-PHARMed platform, asks to re-register (16-01-2025)
- Clear labelling of industrial & medical oxygen must, PMO tells health ministry (16-01-2025)
- Himachal to form Special Task Force to Combat Drug Abuse (16-01-2025)
- SC warns States/UTs of Contempt Proceedings over inaction on Misleading Advertisements (16-01-2025)
- 3600 Proxyvon capsule consignment going to Nepal caught (15-01-2025)
- Three arrested with 900 cough syrup Bottles worth Rs 2 lakh (15-01-2025)
- Bengal 'expired' saline death case: Autopsy report hints at multi-organ failure (15-01-2025)